NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?)

Autor: Stienen, S, Salah, K, Moons, AH, Bakx, AL, van Pol, P, Kortz, RAM, Ferreira, JP, Marques, I, Schroeder-Tanka, JM, Keijer, JT, Bayes-Genis, A, Tijssen, JGP, Pinto, YM, Kok, WE

Publikováno v: Circulation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

BACKGROUND: The concept of natriuretic peptide guidance has been extensively studied in patients with chronic heart failure (HF), with only limited success. The effect of NT-proBNP (N-terminal probrain natriuretic peptide)-guided therapy in patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::24bb72115416697e817ca1acc2fd3ae4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5689

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Outpatient treatment of worsening heart failure with intravenous diuretics: first results from a multicentre 2-year experience.

Autor: Wierda E; Department of Cardiology, Dijklander Ziekenhuis, Hoorn, The Netherlands., van Maarschalkerwaart WWA; Department of Cardiology, OLVG, Amsterdam, The Netherlands., van Seumeren E; Department of Cardiology, OLVG, Amsterdam, The Netherlands., Dickhoff C; Department of Cardiology, Dijklander Ziekenhuis, Hoorn, The Netherlands., Montanus I; Department of Cardiology, OLVG, Amsterdam, The Netherlands., de Boer D; Department of Cardiology, Dijklander Ziekenhuis, Hoorn, The Netherlands., Kop E; Department of Cardiology, OLVG, Amsterdam, The Netherlands., de Mol BAJM; Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands., Schroeder-Tanka JM; Department of Cardiology, OLVG, Amsterdam, The Netherlands., van Heerbeek L; Department of Cardiology, OLVG, Amsterdam, The Netherlands.

Publikováno v: ESC heart failure [ESC Heart Fail] 2023 Feb; Vol. 10 (1), pp. 594-600. Date of Electronic Publication: 2022 Nov 14.

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.

Autor: Salah K; 1 Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands.; 2 Department of Radiology and Nuclear Medicine Radboud University Medical Center Nijmegen the Netherlands., Stienen S; 1 Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands.; 3 INSERM Centre d'Investigations Cliniques Plurithématique Université de Lorraine CHRU de Nancy Nancy France., Moons AHM; 4 Department of Cardiology Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam the Netherlands., Bakx ALM; 5 Department of Cardiology BovenIJ ziekenhuis Amsterdam the Netherlands., van Pol PE; 6 Department of Cardiology Alrijne ziekenhuis Leiderdorp the Netherlands., Kortz RAM; 7 Department of Cardiology Flevoziekenhuis Almere the Netherlands., Ferreira JP; 8 Cardiovascular Research and Development Unit Department of Physiology and Cardiothoracic Surgery Faculty of Medicine University of Porto Porto Portugal.; 9 INSERM Centre d'Investigations Cliniques Plurithématique 1433 INSERM U1116 Université de Lorraine CHRU de Nancy F-CRIN INI-CRCT Nancy France., Marques I; 10 Department of Internal Medicine Centro Hospitalar do Porto Instituto de Ciências Biomédicas de Abel Salazar University of Porto Porto Portugal., Schroeder-Tanka JM; 11 Department of Cardiology Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam the Netherlands., Keijer JT; 12 Department of Cardiology Tergooiziekenhuizen Blaricum the Netherlands., Bayes-Genis A; 13 Department of Cardiology Hospital Universitari Germans Trias i Pujol Barcelona Spain., Pinto YM; 1 Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands., Tijssen JG; 1 Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands., Kok WE; 1 Heart Center Department of Clinical and Experimental Cardiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center University of Amsterdam Amsterdam the Netherlands.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2019 Jul 16; Vol. 8 (14), pp. e010309. Date of Electronic Publication: 2019 Jul 12.

NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).

Autor: Stienen S; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.S., K.S., J.G.P.T., Y.M.P., W.E.K.)., Salah K; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.S., K.S., J.G.P.T., Y.M.P., W.E.K.)., Moons AH; Department of Cardiology, Slotervaartziekenhuis, Amsterdam, The Netherlands (A.H.M.)., Bakx AL; Department of Cardiology, BovenIJ Ziekenhuis, Amsterdam, The Netherlands (A.L.B.)., van Pol P; Department of Cardiology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands (P.v.P.)., Kortz RAM; Department of Cardiology, Flevoziekenhuis, Almere, The Netherlands (R.A.M.K.)., Ferreira JP; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal (J.P.F.).; INSERM, Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, CHRU de Nancy, France (J.P.F.)., Marques I; Department of Internal Medicine, Centro Hospitalar do Porto, Instituto de Ciências Biomédicas de Abel Salazar, University of Porto, Portugal (I.M.)., Schroeder-Tanka JM; Department of Cardiology, St Lucas Andreas Ziekenhuis, Amsterdam, The Netherlands (J.M.S.-T.)., Keijer JT; Department of Cardiology, Tergooiziekenhuizen, Blaricum, The Netherlands (J.T.K.)., Bayés-Genis A; Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain (A.B.-G.)., Tijssen JGP; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.S., K.S., J.G.P.T., Y.M.P., W.E.K.)., Pinto YM; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.S., K.S., J.G.P.T., Y.M.P., W.E.K.)., Kok WE; Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands (S.S., K.S., J.G.P.T., Y.M.P., W.E.K.). w.e.kok@amc.uva.nl.

Publikováno v: Circulation [Circulation] 2018 Apr 17; Vol. 137 (16), pp. 1671-1683. Date of Electronic Publication: 2017 Dec 14.